These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1360329)

  • 1. Dual colour flow cytometry of p53 and c-erbB-2 expression related to DNA aneuploidy in primary and metastatic breast cancer.
    Clark JS; George WD; Campbell AM
    Cancer Lett; 1992 Oct; 66(3):193-200. PubMed ID: 1360329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Internal mammary nodal status is a more reliable prognostic factor than DNA ploidy and c-erb B-2 expression in patients with breast cancer.
    Noguchi M; Koyasaki N; Ohta N; Kitagawa H; Earashi M; Thomas M; Miyazaki I; Mizukami Y
    Arch Surg; 1993 Feb; 128(2):242-6. PubMed ID: 8094282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.
    Isola J; Visakorpi T; Holli K; Kallioniemi OP
    J Natl Cancer Inst; 1992 Jul; 84(14):1109-14. PubMed ID: 1352359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of c-erbB-2 amplification and DNA aneuploidy. Analysis in 78 patients with node-negative breast cancer.
    Babiak J; Hugh J; Poppema S
    Cancer; 1992 Aug; 70(4):770-6. PubMed ID: 1353701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
    Hemmer J; Polackova J
    Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-erbB-2/c-erbA co-amplification indicative of lymph node metastasis, and c-myc amplification of high tumour grade, in human breast carcinoma.
    Tavassoli M; Quirke P; Farzaneh F; Lock NJ; Mayne LV; Kirkham N
    Br J Cancer; 1989 Oct; 60(4):505-10. PubMed ID: 2572268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
    Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
    Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
    Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53, EGF receptor and c-erbB-2 expression in human breast cancer.
    Horak E; Smith K; Bromley L; LeJeune S; Greenall M; Lane D; Harris AL
    Oncogene; 1991 Dec; 6(12):2277-84. PubMed ID: 1685017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. c-erbB-3 protein expression in ovarian tumours.
    Simpson BJ; Weatherill J; Miller EP; Lessells AM; Langdon SP; Miller WR
    Br J Cancer; 1995 Apr; 71(4):758-62. PubMed ID: 7710941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
    Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
    Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
    Schimmelpenning H; Eriksson ET; Falkmer UG; Azavedo E; Svane G; Auer GU
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):433-40. PubMed ID: 1350695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous analysis of c-erbB-2 expression and DNA content in breast cancer using flow cytometry.
    Stål O; Sullivan S; Sun XF; Wingren S; Nordenskjöld B
    Cytometry; 1994 Jun; 16(2):160-8. PubMed ID: 7924685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
    Li BD; Bauer KD; Carney WP; Duda RB
    J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.
    Smith CA; Pollice AA; Gu LP; Brown KA; Singh SG; Janocko LE; Johnson R; Julian T; Hyams D; Wolmark N; Sweeney L; Silverman JF; Shackney SE
    Clin Cancer Res; 2000 Jan; 6(1):112-26. PubMed ID: 10656439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine papillary serous adenocarcinoma. A 10-case study of p53 and c-erbB-2 expression and DNA content.
    Prat J; Oliva E; Lerma E; Vaquero M; Matías-Guiu X
    Cancer; 1994 Sep; 74(6):1778-83. PubMed ID: 7915964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.